

Anti-LMO2 (Y300214) by Applied Biological Materials (ABM) targets LMO2, a LIM-domain transcription factor expressed in germinal center B cells and used in research characterizing GCB-DLBCL, follicular lymphoma, and angiosarcoma. For research use only.